BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34406563)

  • 41. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer.
    Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H
    Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 43. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
    Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
    Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indication and benefit of pelvic sidewall dissection for rectal cancer.
    Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
    Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer].
    Pan YS; Wan YL; Liu YC; Wang X; Wu T
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
    Oki E; Shimokawa M; Ando K; Murata A; Takahashi T; Maeda K; Kusumoto T; Munemoto Y; Nakanishi R; Nakashima Y; Saeki H; Maehara Y
    Surgery; 2019 Mar; 165(3):586-592. PubMed ID: 30314724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and surgical factors associated with organ/space surgical site infection after laparoscopic gastrectomy for gastric cancer.
    Kosuga T; Ichikawa D; Komatsu S; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Surg Endosc; 2017 Apr; 31(4):1667-1674. PubMed ID: 27506433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicenter surveillance study of surgical site infection and its risk factors in radical resection of colon or rectal carcinoma.
    Du M; Liu B; Li M; Cao J; Liu D; Wang Z; Wang Q; Xiao P; Zhang X; Gao Y; Zeng H; Yang J; Xu X; Huang Y; Zhang Q; Zhang B; Chen W; Shi J; Fan S; Zhang F; Yang J; Yang H; Ding Z; Li H; Xiao S; Ran S; Zhai H; Wang F; Xing Y; Suo J; Liu Y
    BMC Infect Dis; 2019 May; 19(1):411. PubMed ID: 31088389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for surgical site infection after gastrectomy with D2 lymphadenectomy.
    Ozalp N; Zülfikaroğlu B; Göçmen E; Acar A; Ekiz I; Koç M; Tez M
    Surg Today; 2009; 39(11):1013-5. PubMed ID: 19882329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type.
    Morohashi H; Sakamoto Y; Miura T; Ichinohe D; Umemura K; Akaishi T; Sato K; Kuwata D; Yamazaki K; Wakiya T; Hakamada K
    Int J Colorectal Dis; 2021 Jun; 36(6):1251-1261. PubMed ID: 33527145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study.
    Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Yamaguchi S
    J Gastrointest Surg; 2021 Jul; 25(7):1866-1874. PubMed ID: 33078319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Outcomes of Total Mesorectal Excision and Lateral Lymph Node Dissection following Neoadjuvant Chemotherapy for Lower Rectal Cancer with Lateral Lymph Node Metastasis].
    Morohashi H; Uchida C; Ogasawara H; Hara Y; Akaishi T; Yachi T; Wakasa Y; Mitsuhashi Y; Tsuruta S; Sato K; Yoshida T; Umetsu S; Hasebe T; Suto A; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1803-1805. PubMed ID: 30692359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
    Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Totally extraperitoneal approach to laparoscopic lateral lymph node dissection for patients with recurrent lateral pelvic lymph nodes after rectal cancer surgery: a novel technique-M TEP LLND.
    Masubuchi S; Okuda J; Hamamoto H; Ishii M; Osumi W; Yamamoto M; Inoue Y; Tanaka K; Uchiyama K
    Surg Today; 2019 Nov; 49(11):981-984. PubMed ID: 30972565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and treatment of positive pelvic sidewall lymph nodes in patients with rectal cancer.
    Jones HG; Radwan RW; Sams E; Gibby M; Coomer W; Jeffries J; Codd RJ; Williams GL; Taylor G; Horwood J
    Colorectal Dis; 2020 Nov; 22(11):1560-1567. PubMed ID: 32506534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Minimizing Risks in Minimally Invasive Surgery: Rates of Surgical Site Infection Across Subtypes of Laparoscopic Hysterectomy.
    Brown O; Geynisman-Tan J; Gillingham A; Collins S; Lewicky-Gaupp C; Kenton K; Mueller M
    J Minim Invasive Gynecol; 2020; 27(6):1370-1376.e1. PubMed ID: 31672589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.
    Anania G; Davies RJ; Arezzo A; Bagolini F; D'Andrea V; Graziosi L; Di Saverio S; Popivanov G; Cheruiyot I; Cirocchi R; Donini A
    Int J Colorectal Dis; 2021 Nov; 36(11):2321-2333. PubMed ID: 34125269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.